Literature DB >> 5052051

Vocal rehabilitation after partial or total laryngectomy.

T C Calcaterra, D H Zwitman.   

Abstract

One of the paramount concerns of a patient who must undergo surgical intervention for laryngeal cancer is the effect on his speech. The type of operation is based on the anatomic extent of the cancer, but each procedure presents inherent problems in vocal rehabilitation. Glottic incompetence is the primary deficit to be overcome following hemilaryngectomy, whereas the aspirate voice is the principal problem with supraglottic laryngectomy. When the larynx must be sacrificed by total laryngectomy, the patient attempts to learn esophageal speech. If this fails, a vibrating sound source for speech can be acquired, either by the construction of a trachealpharyngeal communication or by use of a manual electric vibrator.

Entities:  

Mesh:

Year:  1972        PMID: 5052051      PMCID: PMC1518581     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  7 in total

1.  REHABILITATION OF THE LARYNGECTOMEE.

Authors:  H MARTIN
Journal:  Cancer       Date:  1963-07       Impact factor: 6.860

2.  Glottic reconstruction and wound rehabilitation. Procedures in partial laryngectomy.

Authors:  J J CONLEY
Journal:  Arch Otolaryngol       Date:  1961-09

3.  Management of raw areas in the larynx.

Authors:  J A HARPMAN
Journal:  Arch Otolaryngol       Date:  1961-06

4.  Vocal rehabilitation by autogenous vein graft.

Authors:  J J CONLEY
Journal:  Ann Otol Rhinol Laryngol       Date:  1959-12       Impact factor: 1.547

5.  A method of therapy for paralytic conditions of the mechanisms of phonation, respiration and glutination.

Authors:  E FROESCHELS; S KASTEIN; D A WEISS
Journal:  J Speech Hear Disord       Date:  1955-12

6.  Hemilaryngectomy--a modified technique for cordal carcinoma with extension posteriorly.

Authors:  M L SOM
Journal:  AMA Arch Otolaryngol       Date:  1951-11

7.  Partial laryngectomy and laryngoplasty: a technique and review.

Authors:  B J Bailey
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1966 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.